Shane Kovacs
Director of Finance/CFO at OLEMA PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 2024-03-30
Network origin in Shane Kovacs first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Credit Suisse (Australia) Ltd.
 Credit Suisse (Australia) Ltd. Investment Banks/BrokersFinance Credit Suisse (Australia) Ltd. (Credit Suisse Australia) is a broker/dealer firm headquartered in Sydney, Australia. The firm was founded in 1999 and is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Australia offers global securities sales, trading and execution, prime brokerage, underwriting, and comprehensive investment research for corporate and institutional investors.
33
| Subsidiary | Investment Banks/Brokers | 33 |
| Public Company | Pharmaceuticals: Major | 22 | |
Knopp Neurosciences, Inc.
 Knopp Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY.
3
| Subsidiary | Investment Managers | 3 |
BlueRock Therapeutics LP
 BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company based in Cambridge, MA. The private company is focused on creating cellular medicines to reverse devastating diseases such as neurological, cardiovascular, immunological, and ophthalmic diseases. BlueRock Therapeutics's lead clinical program, Bemdaneprocel, is in phase I clinical trials for Parkinson's disease. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. The company was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shane Kovacs via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Institutional Sales Analyst-Equity | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
LaunchCyte LLC
 LaunchCyte LLC Investment ManagersFinance LaunchCyte LLC (LaunchCyte) is a venture capital firm founded in 2000 by Tom A.Petzinger and Barbara Bailey Carryer. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Founder Director/Board Member | |
Crystalplex Corp.
 Crystalplex Corp. SemiconductorsElectronic Technology Crystalplex Corp. operates a biochemistry and diagnostics laboratory that specializes in nanotechnology for the life sciences industry. Its proprietary technology, SapphireTM QDs provides a stable crystal design, flexible polymer matrix morphology, and meets environmentally responsible yet demanding performance requirements for high-end consumer electronics applications such as liquid crystal display televisions, displays, and high-CRI architectural lighting. The company was founded by Thomas A. Petzinge Jr. in 2004 and is headquartered in Pittsburgh, PA. | Semiconductors | Founder Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| University of Notre Dame | College/University | Undergraduate Degree | |
Knopp Biosciences LLC
 Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member Founder Founder Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| TURG POIN | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Pittsburgh | College/University | Doctorate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Sydney | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Undergraduate Degree Graduate Degree | |
WGBH Educational Foundation
 WGBH Educational Foundation BroadcastingConsumer Services WGBH Educational Foundation operates television stations. The non-profit company is based in Boston, MA and has subsidiaries in United States. The company was founded in 1951 by Ralph Lowell. Jonathan C. Abbott has been the CEO of the company since 1998. | Broadcasting | Director/Board Member | |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
Citigroup Global Markets Australia Pty Ltd.
 Citigroup Global Markets Australia Pty Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Australia Pty Ltd. (Citi Australia) is the brokerage arm of Citigroup Global Markets Australia Holdings Pty Ltd., ultimately held by Citigroup, Inc., (NYSE: C) in the US. Headquartered in Sydney with additional office in Melbourne, Citi Australia provides brokerage services to Australian consumers, corporations, institutions and governments. The firm participate in sales and trading across all asset classes including equities, corporate, government and agency bonds, mortgage-backed securities, syndicated loans, structured products, foreign exchange and futures. | Investment Banks/Brokers | Chief Executive Officer Director of Research - Equity Analyst-Equity | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| KITE PHARMA INC | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Deutsche Bank AG (Australia) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
rampersand
 rampersand Investment ManagersFinance Rampersand (Rampersand) is venture capital firm founded in 2013 by Paul Naphtali and Jim Cassidy. The firm is headquartered in Cremorne, Australia. | Investment Managers | Private Equity Investor Private Equity Investor | |
Commonwealth Securities Ltd.
 Commonwealth Securities Ltd. Investment Banks/BrokersFinance Commonwealth Securities Ltd. (CommSec) is the securities brokerage subsidiary of Commonwealth Bank of Australia (ASX: CBA ). Headquartered in Sydney, CommSec was founded in 1995 and offers a range of brokerage products and services including online trading, cash management, margin lending, and international share trading to retail cliens. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Biotechnology | Director/Board Member Director/Board Member | |
Regal Partners Ltd. (Investment Management)
 Regal Partners Ltd. (Investment Management) Investment ManagersFinance Regal Partners Ltd. (Investment Management) (RPL-IM) is the asset management division of Regal Partners Ltd. (ASX: RPL) in Australia. The firm was founded by Robert M. P. Luciano in 2008 as VGI Partners Ltd. Headquartered in Sydney, Regal Partners-IM manages capital for a select number of pre-qualified, high net worth individuals, family offices and other wholesale clients. Capital management is achieved through managed investment funds, separately managed accounts and Australian listed investment companies. | Investment Managers | Portfolio Manager-Equities | |
Youth Communication/New York Center, Inc.
 Youth Communication/New York Center, Inc. Publishing: Books/MagazinesConsumer Services Youth Communication/New York Center, Inc. engages in publishing magazines, books, and other materials. It offers workshops and lesson plans for educators who want to use its stories in schools, after school programs, and foster care agencies. The company was founded in 1980 and is headquartered in New York, NY. | Publishing: Books/Magazines | Director/Board Member | |
| Newton-Wellesley Health Care System, Inc. | Director/Board Member |
Statistics
International
| United States | 37 |
| Australia | 10 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 16 |
| Finance | 11 |
| Electronic Technology | 2 |
| Energy Minerals | 2 |
Operational
| Director/Board Member | 188 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 50 |
| Analyst-Equity | 46 |
| Undergraduate Degree | 43 |
Most connected contacts
| Insiders | |
|---|---|
| Ian Clark | 35 |
| Jerel Davis | 29 |
| Andy Rappaport | 27 |
| Francis McCormick | 21 |
| Pamela Klein | 19 |
| Jeff McCormick | 16 |
| Cynthia Butitta | 16 |
| Sandra Horning | 14 |
| Graham Walmsley | 13 |
| Damien Hannes | 13 |
| Benjamin Gomez | 13 |
| J. Garland | 13 |
| Thomas Petzinger | 12 |
| Michael E. Bozik | 11 |
| Martin Casey | 11 |
- Stock Market
- Insiders
- Shane Kovacs
- Company connections
